JP2013504075A - 疾患組織病理の新規バイオマーカー - Google Patents

疾患組織病理の新規バイオマーカー Download PDF

Info

Publication number
JP2013504075A
JP2013504075A JP2012528396A JP2012528396A JP2013504075A JP 2013504075 A JP2013504075 A JP 2013504075A JP 2012528396 A JP2012528396 A JP 2012528396A JP 2012528396 A JP2012528396 A JP 2012528396A JP 2013504075 A JP2013504075 A JP 2013504075A
Authority
JP
Japan
Prior art keywords
protein
multiple sclerosis
fgf
anosmin
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012528396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504075A5 (cg-RX-API-DMAC7.html
Inventor
カストロ スブリエ， フェルナンド デ
ロペス， ディエゴ クレモント
ムニョス， マリア クリスティーナ オルテガ
サナゲリコ， フランシスコ ハビエル アレンサナ
Original Assignee
フンダシオン ホスピタル ナシオナル デ パラプレジコス パラ ラ インベスティガシオン イ ラ インテグラシオン （フーンパイイン）
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200930661A external-priority patent/ES2356540B1/es
Priority claimed from ES201030090A external-priority patent/ES2369099B1/es
Application filed by フンダシオン ホスピタル ナシオナル デ パラプレジコス パラ ラ インベスティガシオン イ ラ インテグラシオン （フーンパイイン） filed Critical フンダシオン ホスピタル ナシオナル デ パラプレジコス パラ ラ インベスティガシオン イ ラ インテグラシオン （フーンパイイン）
Publication of JP2013504075A publication Critical patent/JP2013504075A/ja
Publication of JP2013504075A5 publication Critical patent/JP2013504075A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP2012528396A 2009-09-07 2010-09-07 疾患組織病理の新規バイオマーカー Pending JP2013504075A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ESP200930661 2009-09-07
ES200930661A ES2356540B1 (es) 2009-09-07 2009-09-07 Método para predecir las características histopatológicas de las lesiones de un sujeto con una enfermedad desmielinizante del sistema nervioso central.
ESP201030090 2010-01-25
ES201030090A ES2369099B1 (es) 2010-01-25 2010-01-25 La proteina Anosmina-1 como biomarcador para la clasificación histopatológica de lesiones de un sujeto con enfermedad desmielinizante del Sistema Nervioso Central.
PCT/ES2010/070584 WO2011045456A2 (es) 2009-09-07 2010-09-07 Nuevos biomarcadores de la histopatología de enfermedades desmielinizantes

Publications (2)

Publication Number Publication Date
JP2013504075A true JP2013504075A (ja) 2013-02-04
JP2013504075A5 JP2013504075A5 (cg-RX-API-DMAC7.html) 2013-10-24

Family

ID=43334531

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528396A Pending JP2013504075A (ja) 2009-09-07 2010-09-07 疾患組織病理の新規バイオマーカー

Country Status (6)

Country Link
US (1) US20120252688A1 (cg-RX-API-DMAC7.html)
EP (1) EP2477030A2 (cg-RX-API-DMAC7.html)
JP (1) JP2013504075A (cg-RX-API-DMAC7.html)
AU (1) AU2010306515A1 (cg-RX-API-DMAC7.html)
CA (1) CA2773527A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011045456A2 (cg-RX-API-DMAC7.html)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506516A (ja) * 1997-04-28 2002-02-26 アンスティテュ ナシオナル ドゥ ラ サーント エ ドゥ ラ ルシェルシュ メディカル（イ エン エス ウ エル エム） 自己免疫の病理を検出するための方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506516A (ja) * 1997-04-28 2002-02-26 アンスティテュ ナシオナル ドゥ ラ サーント エ ドゥ ラ ルシェルシュ メディカル（イ エン エス ウ エル エム） 自己免疫の病理を検出するための方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN5012017485; ＭＥＳＳＥＲＳＭＩＴＨ　Ｄ　Ｊ: 'ＦＩＢＲＯＢＬＡＳＴ　ＧＲＯＷＴＨ　ＦＡＣＴＯＲ　２（ＦＧＦ２）　ＡＮＤ　ＦＧＦ　ＲＥＣＥＰＴＯＲ　ＥＸＰＲＥＳＳＩＯＮ　ＩＮ　ＡＮ　ＥＸＰＥＲＩＭＥＮＴＡＬ　以下備考' ＪＯＵＲＮＡＬ　ＯＦ　ＮＥＵＲＯＳＣＩＥＮＣＥ　ＲＥＳＥＡＲＣＨ Ｖ６２　Ｎ２, 20001015, Ｐ２４１-２５６ *

Also Published As

Publication number Publication date
CA2773527A1 (en) 2011-04-21
WO2011045456A9 (es) 2011-11-03
EP2477030A2 (en) 2012-07-18
US20120252688A1 (en) 2012-10-04
WO2011045456A3 (es) 2011-06-30
AU2010306515A1 (en) 2012-04-12
WO2011045456A2 (es) 2011-04-21

Similar Documents

Publication Publication Date Title
US12422433B2 (en) Blood biomarker that predicts persistent cognitive dysfunction after concussion
JP6225157B2 (ja) 緑内障の診断方法
KR102064060B1 (ko) 뇌의 베타 아밀로이드 축적 감별용 혈중 바이오마커
Giovannoni Multiple sclerosis cerebrospinal fluid biomarkers
CA2913524C (en) Method for aiding differential diagnosis of stroke
Gresle et al. Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis
AU2018247291A1 (en) Biomarker-based methods and biochips for aiding the diagnosis of stroke
Agnello et al. The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases
Signorile et al. Prototype of multiplex bead assay for quantification of three serum biomarkers for in vitro diagnosis of endometriosis
EP3639037B1 (en) Method for diagnosing stroke using a combination of biomarkers
JP2013504075A (ja) 疾患組織病理の新規バイオマーカー
EP3765854A1 (en) Markers of synaptopathy in neurodegenerative disease
Jothi et al. Development and validation of a novel biomarker panel for early detection of neurodegenerative diseases
ES2356540B1 (es) Método para predecir las características histopatológicas de las lesiones de un sujeto con una enfermedad desmielinizante del sistema nervioso central.
ES2369099B1 (es) La proteina Anosmina-1 como biomarcador para la clasificación histopatológica de lesiones de un sujeto con enfermedad desmielinizante del Sistema Nervioso Central.
WO2024040103A2 (en) Methods for early diagnosis and treatment of open neural tube defects

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130905

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130905

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140327

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150407